loadpatents
name:-0.015336036682129
name:-0.01170802116394
name:-0.0014188289642334
L'Heureux; Alexandre Patent Filings

L'Heureux; Alexandre

Patent Applications and Registrations

Patent applications and USPTO patent grants for L'Heureux; Alexandre.The latest application filed is for "7-hydroxy-indolinyl antagonists of p2y1 receptor".

Company Profile
0.12.12
  • L'Heureux; Alexandre - Ste-Julie CA
  • L'Heureux; Alexandre - Quebec N/A CA
  • L'Heureux; Alexandre - Longueuil CA
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
7-hydroxy-indolinyl antagonists of P2Y.sub.1 receptor
Grant 9,540,323 - L'Heureux , et al. January 10, 2
2017-01-10
7-hydroxy-indolinyl Antagonists Of P2y1 Receptor
App 20150259286 - L'Heureux; Alexandre ;   et al.
2015-09-17
Disubstituted-aminodifluorosulfinium salts, process for preparing same and method of use as deoxofluorination reagents
Grant 8,680,332 - Couturier , et al. March 25, 2
2014-03-25
Heteroaryl compounds as P2Y.sub.1 receptor inhibitors
Grant 8,273,772 - Sutton , et al. September 25, 2
2012-09-25
Disubstituted-aminodifluorosulfinium Salts, Process For Preparing Same And Method Of Use As Deoxofluorination Reagents
App 20120108801 - Couturier; Michel A. ;   et al.
2012-05-03
Heteroaryl Compounds As P2y1 Receptor Inhibitors
App 20100093689 - Sutton; James C. ;   et al.
2010-04-15
Urea antagonists of P2Y.sub.1receptor useful in the treatment of thrombotic conditions
Grant 7,674,828 - Chao , et al. March 9, 2
2010-03-09
Heteroaryl compounds as P2Y.sub.1 receptor inhibitors
Grant 7,645,778 - Sutton , et al. January 12, 2
2010-01-12
Urea Antagonists Of P2y1 Receptor Useful In The Treatment Of Thrombotic Conditions
App 20080280905 - Chao; Hannguang J. ;   et al.
2008-11-13
Urea antagonists of P2Y.sub.1 receptor useful in the treatment of thrombotic conditions
Grant 7,388,021 - Chao , et al. June 17, 2
2008-06-17
Arylcyclopropylcarboxylic amides as potassium channel openers
Grant 7,144,881 - Wu , et al. December 5, 2
2006-12-05
3-Heterocyclic benzylamide derivatives as potassium channel openers
Grant 7,135,472 - Wu , et al. November 14, 2
2006-11-14
Heteroaryl compounds as P2Y1 receptor inhibitors
App 20060173002 - Sutton; James C. ;   et al.
2006-08-03
1-aryl-2-hydroxyethyl amides as potassium channel openers
Grant 7,045,551 - Wu , et al. May 16, 2
2006-05-16
Azaindole kinase inhibitors
App 20060058304 - Bhide; Rajeev S. ;   et al.
2006-03-16
Urea antagonists of P2Y1 receptor useful in the treatment of thrombotic conditions
App 20050267119 - Chao, Hannguang J. ;   et al.
2005-12-01
Azaindole kinase inhibitors
Grant 6,969,717 - Bhide , et al. November 29, 2
2005-11-29
Cinnamide derivatives as KCNQ potassium channel modulators
Grant 6,831,080 - Wu , et al. December 14, 2
2004-12-14
1-aryl-2-hydroxyethyl amides as potassium channel openers
App 20040122007 - Wu, Yong-Jin ;   et al.
2004-06-24
Arylcyclopropylcarboxylic amides as potassium channel openers
App 20040110754 - Wu, Yong-Jin ;   et al.
2004-06-10
3-Heterocyclic benzylamide derivatives as potassium channel openers
App 20040106621 - Wu, Yong-Jin ;   et al.
2004-06-03
Azaindole kinase inhibitors
App 20040063707 - Bhide, Rajeev S. ;   et al.
2004-04-01
Cinnamide derivatives as KCNQ potassium channel modulators
App 20030166650 - Wu, Yong-Jin ;   et al.
2003-09-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed